GIP受体 is one of those subjects where the details matter more than the headlines. This page pulls together the background, the mechanisms, and the practical points readers ask about most.
Updated 2026-05-07. Numbers and descriptions here follow the published literature rather than marketing material.
该分子是经过结构修饰的合成肽,通过脂肪酸侧链与白蛋白结合,从而延长循环时间。皮下给药后,药物逐步释放并分布至组织。降解主要依赖蛋白酶,肾脏清除占次要地位。人体半衰期以天为单位,但准确数值随检测方法和个体差异而变;组织分布与受体占有率仍是开放问题。
临床研究通常测量体重、腰围、空腹血糖、糖化血红蛋白和血脂,并记录不良事件。药代动力学评估关注浓度-时间曲线,药效动力学评估关注代谢标志物变化。体重下降由能量摄入减少、能量消耗变化和脂肪组织重塑共同造成,具体权重仍不明确。研究之间的终点定义和随访时长差异使横向比较复杂。
瑞他鲁肽同时激活GLP-1受体、GIP受体和胰高血糖素受体,这三者均属于B类G蛋白偶联受体。受体激活后主要经cAMP信号通路传递效应。GLP-1成分与食欲抑制和胃排空延缓相关,GIP成分影响脂肪组织与胰岛素分泌,胰高血糖素成分则促进肝糖输出和能量消耗。各受体贡献的相对比例在人体中尚未完全量化。
Human evidence remains limited to controlled studies. A phase 2 trial in adults with obesity reported large, dose-dependent reductions in body weight over 48 weeks, with gastrointestinal events as the most frequently recorded adverse effect. Phase 3 programs designated TRIUMPH, for obesity, and TRANSCEND, for type 2 diabetes, are intended to confirm efficacy and to characterize safety in larger populations. Related studies are examining conditions such as knee osteoarthritis in people with obesity and metabolic liver disease. Open questions include long-term tolerability, effects on lean mass, and what happens after treatment is stopped.
Retatrutide is an investigational synthetic peptide that acts on three receptor targets at once: glucose-dependent insulinotropic polypeptide, glucagon-like peptide-1, and glucagon. It is developed by Eli Lilly and appears in the literature and in trial registries under the code LY3437943. The molecule belongs to a class of engineered peptides designed to resist rapid breakdown and permit infrequent subcutaneous administration. No regulatory agency has approved it for clinical use, and all available human data come from controlled trials rather than from routine practice.
| Property | Value | Notes |
|---|---|---|
| 分子量 | 约4.7 kDa | 合成肽,具体数值随形式而变化 |
| 外观 | 白色至类白色冻干粉 | 常见于多肽制剂 |
| 溶解度类别 | 水溶性 | 可溶于水性缓冲液,pH影响溶解 |
| 典型储存温度 | -20°C或更低 | 冻干粉长期保存 |
| 典型分析方法 | 反相高效液相色谱与质谱 | 用于纯度、身份和杂质分析 |
However, laboratory supplies at Leuven were in shortage, therefore he enrolled in a programme to earn a degree in chemistry at the Cancer Institute. His research on insulin was summed up in a 400-page book titled Glucose, Insuline et Diabète (Glucose, Insulin and Diabetes) published in 1945, simultaneously in Brussels and Paris. The book was condensed into a technical dissertation which earned him the most advanced degree at the university level agrégation de l'enseignement supérieur (an equivalent of a doctorate – he called it "a sort of glorified PhD") in 1945. His thesis was followed by a number of scientific publications. He subsequently obtained a MSc in chemistry in 1946, for which he worked on the purification of penicillin. To enhance his skill in biochemistry, he trained in the laboratory of Hugo Theorell (who later won The Nobel Prize in Physiology or Medicine in 1955) at the Nobel Medical Institute in Stockholm for 18 months during 1946–47. In 1947, he received a financial assistance as Rockefeller Foundation fellow and worked for six months with Carl and Gerti Cori at Washington University in St. Louis (the husband and wife were joint winners of The Nobel Prize in Physiology or Medicine in 1947).
=== EC 1.8.1 With NAD+ or NADP+ as acceptor === EC 1.8.1.1: deleted EC 1.8.1.2: sulfite reductase (NADPH) EC 1.8.1.3: deleted; reaction shown to be due to EC 1.14.13.8, flavin-containing monooxygenase EC 1.8.1.4: dihydrolipoyl dehydrogenase EC 1.8.1.5: 2-oxopropyl-CoM reductase (carboxylating) EC 1.8.1.6: cystine reductase EC 1.8.1.7: glutathione-disulfide reductase EC 1.8.1.8: protein-disulfide reductase EC 1.8.1.9: thioredoxin-disulfide reductase EC 1.8.1.10: CoA-glutathione reductase EC 1.8.1.11: asparagusate reductase EC 1.8.1.12: trypanothione-disulfide reductase EC 1.8.1.13: bis-γ-glutamylcystine reductase EC 1.8.1.14: CoA-disulfide reductase EC 1.8.1.15: mycothione reductase EC 1.8.1.16: glutathione amide reductase EC 1.8.1.17: dimethylsulfone reductase EC 1.8.1.18: NAD(P)H sulfur oxidoreductase (CoA-dependent) EC 1.8.1.19: sulfide dehydrogenase EC 1.8.1.20: 4,4′-dithiodibutanoate disulfide reductase EC 1.8.1.21: dissimilatory dimethyldisulfide reductase EC 1.8.1.22: dissimilatory sulfite reductase
Anxiety disorders Bobble-head doll syndrome – a sensation that the skull may fall off the cervical spine Clumsiness and motor delay Cognitive and memory decline Double or blurred vision Dysphagia – a sensation of choking Dyspnea Fatigue Lhermitte's sign Migraine Nausea Neck, shoulder, and jaw pain Occipital headaches Orthostatic intolerance Photophobia Syncope Tenderness at base of skull Tinnitus Tremors Palpitations Vertigo or dizziness Weakness of limbs Symptoms are frequently worsened by a Valsalva maneuver or by being upright for long periods of time. Being upright is problematic because gravity allows increased interaction between the brain stem and the top of the spinal column, increasing symptoms. Lying in the supine position can bring short-term relief. Lying supine eliminates the downward gravitational pull, reducing symptoms to some degree. Lying with the feet somewhat higher and head lower can be helpful in symptom reduction.
In the United States, Utah started screening for GAMT deficiency in all newborns in 2015. New York started screening newborns in late 2018. In 2020, a GAMT-positive infant was identified via newborn screening in Utah, thus providing evidence that a case could be identified from newborn screening. A second infant was identified in New York in 2021. In 2022, a federal advisory committee voted to include GAMT in the Recommended Universal Screening Panel starting in January 2023. In addition to New York and Utah, California, Pennsylvania, Connecticut, Delaware, and Michigan all currently screen for GAMT. Around the world, the state of Victoria, Australia began screening for GAMT in 2004, leading to the diagnosis of a newborn at birth in 2022. In Canada, the provinces of Ontario and British Columbia screen for GAMT.
== Related methods == Alternative specific enrichment methods include MSIA (“mass spectrometric immunoassay”,) in which antibodies are used to enrich target proteins, which are analyzed intact by MS; and hybrid methods in which antibodies are used to enrich target proteins, which are then digested prior to peptide detection by MS.
Sources: en.wikipedia.org
== External links == Safer Nanomaterials and Nanomanufacturing Initiative Archived 2014-08-12 at the Wayback Machine Clean Tech Law & Business Project on Emerging Nanotechnologies Nanotechnology Lab Archived 2019-12-06 at the Wayback Machine National Nanotechnology Initiative The Berkeley Nanosciences and Nanoengineering Institute Nanotechnology: Green Manufacturing Nanotechnology Now "Can nanotechnology be green?" Folia Water – The Safe Water Book, containing 26 nanosilver-impregnated filter papers for water purification.
18 July – Starmer pledges £84m in funding for education, employment and humanitarian projects in Africa and the Middle East designed to stop illegal migration "at source". 19 July – Ukrainian president Volodymyr Zelenskyy visits Downing Street and addresses the cabinet, becoming the first foreign leader to address a British cabinet since 1997, and urges Keir Starmer to "show your leadership" by helping to remove restrictions on the use of weapons supplied to Ukraine. Sunak makes junior appointments to his shadow frontbench team, including some newly elected MPs, meaning 51 of the 121 Conservative MPs in parliament now have shadow ministerial posts. Foreign Secretary David Lammy confirms the UK will resume funding UNRWA, the UN's agency for Palestinian refugees. Shadow Secretary of State for Health and Social Care Victoria Atkins is criticised by House of Commons Deputy Speaker Christopher Chope for her behaviour during a parliamentary debate after she loudly interrupted Steve Reed, the Secretary of State for Environment, Food and Rural Affairs as he addressed the House. 20 July – Figures produced by the Institute for Fiscal Studies suggest the UK government would need to spend an extra £3bn to implement a 5.5% pay rise for teaching and NHS staff. July 2024 Welsh Labour leadership election: Welsh Labour officials agree a timeline for the election, with a new leader to be in place on 14 September. Nominations open for candidates entering the leadership contest.
Oak Ridge National Laboratory displayed that carp and minnow embryos raised in solutions containing plutonium did not hatch; eggs that hatched displayed significant abnormalities when compared to control developed embryos. It revealed that higher concentrations of plutonium have been found to cause issues in marine fauna exposed to the element.
Feminizing hormone therapy is typically used by transgender women, who desire the development of feminine secondary sex characteristics. Individuals who identify as non-binary may also opt-in for feminizing hormone treatment to better align their body with their desired gender expression. Feminizing hormone therapy usually includes medication to suppress testosterone production and induce feminization. Types of medications include estrogens, antiandrogens (testosterone blockers), and progestogens. Most commonly, an estrogen is combined with an antiandrogen to suppress and block testosterone. This allows for demasculinization and promotion of feminization and breast development. Estrogens are administered in various modalities including injection, transdermal patch, and oral tablets. The desired effects of feminizing hormone therapy focus on the development of feminine secondary sex characteristics. These desired effects include: breast tissue development, redistribution of body fat, decreased body hair, reduction of muscle mass, and more. The table below summarizes some of the effects of feminizing hormone therapy in transgender women:
After finding out that Apoth was using children to disseminate a technological drug called Overclock, Mister Sinister modified Overclock to allow Psylocke to interact with Apoth in a cyberspace, killing Apoth, whose remains she delivered to Mister Sinister in exchange for his assistance in keeping this extrajudicial mission a secret from the Krakoan Quiet Council. Following the Apoth incident, Psylocke was assigned to monitor Mister Sinister's new team of Hellions, composed of mutants considered too violent or troubled to assimilate into Krakoan society. The character was later featured as a team member in the Marauders (vol. 2) as the team was refocused on their mission of mutant rescue. Following the fall of Krakoa, Kwannon headlined Psylocke (vol. 2), written by Alyssa Wong with art by Vincenzo Carratù, spun out of the events of Jed MacKay and Ryan Stegman's X-Men (vol. 7) where Kwannon was a team member.
Sources: en.wikipedia.org
Acute and chronic exposure also reduces glutathione reductase, an enzyme that catalyzes the reduction of glutathione disulfide (GSSG) to the sulfhydryl form glutathione (GSH), which is a critical molecule in resisting oxidative stress and maintaining the reducing environment of the cell.
The 1970s saw a shift in audience tastes to high concept films, with five such films made by either George Lucas or Steven Spielberg topping the chart during the 1980s. The 21st century has seen an increasing dependence on franchises and adaptations, with the box-office dominance of films based on pre-existing intellectual property at record levels. Steven Spielberg (1975, 1981, 1982, 1989 and 1993) and Cecil B. DeMille (1932, 1947, 1949, 1952 and 1956) tie as the most represented directors on the chart with five films apiece occupying the annual top spot. William Wyler (1942, 1946, 1959 and 1968) and James Cameron (1991, 1997, 2009 and 2022) are each represented by four films, whilst D. W. Griffith (1915, 1916 and 1920), George Roy Hill (1966, 1969 and 1973) and the Russo brothers (2016, 2018 and 2019) all feature heavily with three films apiece. George Lucas directed three chart-toppers in 1977, 1999 and 2005, but also served in a strong creative capacity as a producer and writer in 1980, 1981, 1983, and 1989 as well. The following directors have also all directed two films on the chart: Frank Lloyd, King Vidor, Frank Capra, Michael Curtiz, Leo McCarey, Alfred Hitchcock, David Lean, Stanley Kubrick, Guy Hamilton, Mike Nichols, William Friedkin, Peter Jackson, Gore Verbinski, and Michael Bay; Mervyn LeRoy, Ken Annakin and Robert Wise are each represented by one solo credit and one shared credit, and John Ford co-directed two films.
C-4 or Composition C-4 is a common variety of the plastic explosive family known as Composition C, which uses RDX as its explosive agent. C-4 is composed of explosives, plastic binder, plasticizer to make it malleable, and usually a marker or odorizing taggant chemical. C-4 has a texture similar to modelling clay and can be molded into any desired shape. C-4 is relatively insensitive and can be detonated only by the shock wave from a detonator or blasting cap. A similar British plastic explosive, also based on RDX but with a plasticizer different from that used in Composition C-4, is known as PE-4 (Plastic Explosive No. 4).
=== 2022–present: Potential seventh studio album, Kinney health issues and cancelled tour === In an April 2022 interview, vocalist William DuVall revealed that he was "sure" Alice in Chains would begin working on their seventh studio album later in the year: We had a lot of time imposed on us and I think we're going through this period of catching up on things that we had planned for 2020 [and] 2021, and we're all finally getting to do that now. So, it's kind of like a stopgap and we're just dealing with all of these stockpiled projects that we had planned a few years back. So once we get back up to speed with things and we get these dates underway in late summer, I'm sure it will spark a whole bunch of ideas for the next Alice in Chains studio album. However, in March 2023, DuVall stated there were "no plans" for new Alice in Chains music. In February 2025, the band announced appearances at Welcome to Rockville in Daytona Beach, Florida, Sonic Temple in Columbus, Ohio, and MMR*B*Q, a festival hosted by WMMR in Camden, New Jersey, alongside three other headlining performances with Chained Saint, a thrash metal band from Florida. The tour was set to kick off at Mohegan Sun Arena in Montville, Connecticut on May 8, when Kinney suffered a medical emergency during soundcheck that evening. The band described the event as "non-life threatening" but were forced to cancel the show; two days later, the entire tour was scrapped.
In 1996, Saccharomyces cerevisiae was the first single-celled, eukaryotic organism to have its entire genome sequenced. This sequencing helped confirm the nearly century of work by mycologists and enologists in identifying different strains of Saccharomyces cerevisiae that are used in beer, bread and winemaking. Today there are several hundred different strains of S. cerevisiae identified. Not all of the strains are suitable for winemaking and even among the strains that are, there is debate among winemakers and scientists about the actual magnitude of differences between the various strains and their potential impact on the wine. Even among strains that have demonstrated distinctive difference when compared among young wines, these differences seem to fade and become less distinctive as the wines age. Some distinct difference among various strains include the production of certain "off-flavor" and aromas that may be temporary (but producing a "stinky fermentation") or could stay with the wine and either have to be dealt with through other winemaking means (such as the presence of volatile sulfur compounds like hydrogen sulfide) or leave a faulty wine. Another difference includes the "vigor" or speed of fermentation (which can also be influenced by other factors beyond yeast selection) with some yeast strains having the tendency to do "fast ferments" while others may take longer to get going.
Sources: en.wikipedia.org
意味着单个分子可同时结合三种代谢受体,而不是只作用于一种。其目的是整合食欲、胰岛素和能量消耗通路,但人体中的协同程度仍在研究。
不是。研究还评估血糖控制、肝脏脂肪、血脂和心血管风险标志物。不同终点的证据成熟度不同。
胰高血糖素成分在人体中的净效应存在争议,因为它可能升高血糖,也可能增加能量消耗。长期平衡和个体差异尚未明确。
It is an investigational peptide that activates three hormone receptors: GIP, GLP-1 and glucagon. It is being studied mainly for obesity and type 2 diabetes, and it is not approved for any clinical use. Published information comes from controlled trials rather than from general practice.